JOSHUA POSTON: Open Payments
NPI 1801133004 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 123 payments from 26 companies in 2025. Trend: 2023 $2,164 · 2024 $2,761 · 2025 $2,105
Food & beverage: $2,105
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $307 |
| AstraZeneca Pharmaceuticals LP | 8 | $209 |
| ABBVIE INC. | 14 | $208 |
| Amgen Inc. | 24 | $191 |
| PFIZER INC. | 9 | $158 |
| GlaxoSmithKline, LLC. | 8 | $145 |
| Xeris Pharmaceuticals, Inc. | 6 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Dexcom, Inc. | 3 | $62 |
Products named: OTEZLA, Ozempic, CAPLYTA, QULIPTA, TRELEGY ELLIPTA, GVOKE HYPOPEN, Kerendia, FARXIGA.
Industry payments across TN — which companies pay providers there.
